Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Perez, E.A., Ballman, K.V., Mashadi-Hossein, A., Tenner, K.S., Kachergus, J.M., Norton, N., Necela, B.M., Carr, J.M., Ferree, S., Perou, C.M., et al. (2017). Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial. J natl cancer inst, Vol.109 (2), pp. 1-8.  show abstract

Prat, A., Cheang, M.C., Galván, P., Nuciforo, P., Paré, L., Adamo, B., Muñoz, M., Viladot, M., Press, M.F., Gagnon, R., et al. (2016). Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. Jama oncol, Vol.2 (10), pp. 1287-1294.  show abstract

Sun, Z., Prat, A., Cheang, M.C., Gelber, R.D. & Perou, C.M. (2015). Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDER. Ann oncol, Vol.26 (1), pp. 70-74.  show abstract

Cheang, M.C., Martin, M., Nielsen, T.O., Prat, A., Voduc, D., Rodriguez-Lescure, A., Ruiz, A., Chia, S., Shepherd, L., Ruiz-Borrego, M., et al. (2015). Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression. The oncologist, Vol.20 (5), pp. 474-482.

Voduc, K.D., Nielsen, T.O., Perou, C.M., Harrell, J.C., Cheng, F., Kennecke, H., Minn, A., Cryns, V.L. & Cheang, M.C. (2015). αB-crystallin expression in breast cancer is associated with brain metastasis. Npj breast cancer, .

Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R.J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015). Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Science translational medicine, Vol.7 (302), pp. 302ra133-302ra133.

Prat, A., Cheang, M.C., Martin, M., Parker, J.S., Carrasco, E., Caballero, R., Tyldesley, S., Gelmon, K., Bernard, P.S., Nielsen, T.O., et al. (2013). Prognostic Significance of Progesterone Receptor-Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer. Journal of clinical oncology, Vol.31 (2), pp. 203-209.

Cheang, M.C., Voduc, K.D., Tu, D., Jiang, S., Leung, S., Chia, S.K., Shepherd, L.E., Levine, M.N., Pritchard, K.I., Davies, S., et al. (2012). Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC CTG MA 5 Randomized Trial. Clinical cancer research, Vol.18 (8), pp. 2402-2412.

Cheang, M.C., Chia, S.K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P.S., Parker, J.S., et al. (2009). Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer. Jnci-journal of the national cancer institute, Vol.101 (10), pp. 736-750.

Cheang, M.C., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S.K., Perou, C.M. & Nielsen, T.O. (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype. Clinical cancer research, Vol.14 (5), pp. 1368-1376.

Parker, J., Mullins, M., Cheang, M.C., Davies, S., Mardis, E., Nielsen, T.O., Ellis, M.J., Marron, S., Perou, C.M. & Bernard, P.S., et al. (2008). A supervised risk predictor of breast cancer based on biological subtypes. Journal of clinical oncology, Vol.26 (15).

Cheang, M.C., van de Rijn, M. & Nielsen, T.O. (2008). Gene expression profiling of breast cancer. Annual review of pathology-mechanisms of disease, Vol.3, pp. 67-97.

Tutt, A., Tovey, H., Cheang, M., Kernaghan, S., Kilburn, L., Gazinska, P., Owen, J., Abraham, J., Barrett, S., Barrett-Lee, P., et al. A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and 2 pre-specified triple negative breast cancer “BRCAness” subgroups: the TNT Trial 3 4. Nature medicine, .

In this section

Research overview Research projects Publications